WCM
REGN icon

Winton Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Winton Capital Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		$8.09M Buy
26,927
+6,318
+31% +$1.95M 0.06% 352
2013
Q4 		$5.67M Buy
20,609
+1,943
+10% +$559K 0.05% 364
2013
Q3 		$5.84M Buy
18,666
+13,875
+290% +$3.65M 0.07% 340
2013
Q2 		$1.08M Buy
+4,791
New +$1.12M 0.01% 493

Other funds holding REGN

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Winton Capital Management's REGN Position: Q1 2014 in Review

Winton Capital Management increased its Regeneron Pharmaceuticals (REGN) stake by 31% in Q1 2014, buying an estimated $1.95M and bringing the position to 26,927 shares worth $8.09M. The position accounts for 0.06% of the portfolio, ranked #352.

Winton Capital Management first reported a position in REGN in Q2 2013 and has held it in 4 quarters since. 453 funds tracked by Wall St. Rank hold REGN as of Q1 2014.

  • Winton Capital Management held 26,927 shares of Regeneron Pharmaceuticals worth $8.09M as of Q1 2014.
  • Winton Capital Management bought 6,318 Regeneron Pharmaceuticals shares in Q1 2014, an estimated $1.95M.
  • Regeneron Pharmaceuticals made up 0.06% of Winton Capital Management's portfolio in Q1 2014, its #352 holding.
  • Winton Capital Management first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 4 quarters since.
  • 453 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2014.

Based on Winton Capital Management's 13F filing for Q1 2014, filed 1 May 2014.